Simon J. Crabb - Publications, H-index & Citations

Simon J. Crabb

University Hospital Southampton NHS Foundation Trust

45H指数

326论文数

9.0K被引数

收录论文 99

发表时间

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study 联合ctDNA和血清PSA动态监测转移性前列腺癌开始一线治疗: 一项前瞻性国家队列研究

Nature Cancer

IF28.5

2026-05-15

OAAI

Anuradha Jayaram; Memuna Rashid; Alison H. M. Reid; Francesco Orlando; Suparna Thakali; Leila Zakka; Miriam Goncalves; Jacqueline O’Dwyer; Constantine Alifrangis; Rob Jones; Elias Pintus; Sarah Needleman; Diletta Bianchini; Anna Wingate; Kenrick Ng; Mark Linch; Ursula McGovern; John Staffurth; Simon J. Crabb; Susannah Brock; Alison Birtle; Osvaldas Vainauskas; Gianmarco Leone; Millenn Chiwewe; Allan Hackshaw; Andre Lopes; Daniel Wetterskog; Francesca Demichelis; Gerhardt Attard

Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial 前列腺癌雄激素剥夺治疗期间针对潮热和盗汗的自助认知行为疗法：MANCAN2随机对照试验

British Journal of Cancer

IF6.8

2026-03-24

OAAI

Simon J. Crabb; Alannah Morgan; Evgenia Stefanopoulou; Louisa Fleure; Gareth O. Griffiths; Cherish Boxall; Sam Wilding; Theodora Nearchou; Sean Ewings; Jacqueline Nuttall; Zina Eminton; Emma Tilt; Emma Whitby; Bernard Siu; Paul Ridley; Lynsey Robson; Jenny Nobes; Joanne Preece; Roger Bacon; Jonathan Martin; Sarah Chamberlain; Deborah Fenlon; Myra Hunter; Alison Richardson

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology Experimental Cancer Medicine Centre (ECMC)网络关于泛癌种测序的共识基因面板的提案：一种德尔菲方法

British Journal of Cancer

IF6.8

2025-11-08

OAAI

Richard Phillips; Bristi Basu; Zohra Butt; Mounia Beloueche; Natalie Cook; Simon J. Crabb; Alastair Greystoke; Darren Hargrave; Robert Jones; Muhammad Yasin Kureeman; Juanita Lopez; Claire McKeeve; Magdalena Meissner; Brent O’Carrigan; Eileen E. Parkes; Milind Ronghe; Patricia Roxburgh; Debashis Sarker; Kienan I. Savage; Paul H. S. Shaw; Stefan Symeonides; Deborah A. Tweddle; Aditi Vedi; Harriet S. Walter; Joanna Zabkiewicz; Gary W. Middleton; Andrew D. Beggs

Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocol 通过使用Enlighten测试测量血浆氨基酸横截面，在确诊和疑似癌症患者队列中进行多肿瘤早期检测: 现代化方案

BMJ OPEN

IF2.3

2025-11-03

OAAI

Wilding, Sam; Goss, Victoria; Sukdao, Wesley; Hamady, Zaed; Lord, Joanne; Coleman, Adam; Pointer, Catherine; Walters, Jocelyn; Herbert, Will; Mclaughlin, Katy; Waugh, Robert; Irvine, Nicola; Oliver, Tom; Soulsby, Irene; Hooper, Julie; Crabb, Simon J.; Griffiths, Gareth; Yates, Emma; Davies, Andrew

Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset 预后免疫疗法评分（PIS）在经帕博利珠单抗治疗的晚期尿路上皮癌患者中的真实世界数据及ARON-2数据集验证

Clinical & Experimental Metastasis

IF3.2

2025-09-06

PREAI

Alessandro Rizzo; Anas Zayed; Elsa Vitale; Sebastiano Buti; Hideki Takeshita; Simon Crabb; Giandomenico Roviello; Emmanuel Seront; Jose Carlos Tapia; Sarah Scagliarini; Lazar Popovic; Ray Manneh Kopp; Halima Abahssain; Mimma Rizzo; Fernando Sabino Marques Monteiro; Raffaella Massafra; Oronzo Brunetti; Daniele Santini; Yüksel Ürün; Rodolfo Montironi; Veronica Mollica; Francesco Massari; Andrey Soares; Matteo Santoni

IUC24406-81 ARTA-ATTACK study: assessment of sarcopenia, frailty, and neurocognitive impairment in patients with prostate cancer treated with androgen receptor-targeted agents: a prospective multicenter observational cohort study IUC24406-81 ARTA-ATTACK研究：评估接受雄激素受体靶向药物治疗的前列腺癌患者中肌肉减少症、虚弱和神经认知功能障碍：一项前瞻性多中心观察性队列研究

The Oncologist

IF0

2025-08-29

OAAI

G Banna; A Maniam; P Rescigno; A Reid; S Crabb; M Maffezzoli; B Smalley

DURANCE: A phase Ib/II study to assess the safety and activity of durvalumab (MEDI4736) in combination with S-488210/S-488211 vaccine in non-muscle invasive bladder cancer DURANCE：一项评估 durvalumab（MEDI4736）联合 S-488210/S-488211 疫苗在非肌层浸润性膀胱癌中的安全性与活性的 Ib/II 期研究

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Leone, G.; Shokri, A.; Szabados, B. E.; Khoo, V.; Crabb, S.; Enting, D.; Powles, T. B.; Ottensmeier, C. H. H.; Quezada, S.; Begum, R.; Musleh, R.; Duggan, M.; Rashid, M. K.; Linch, M.

Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial Capivasertib联合恩扎鲁他胺治疗多西他赛和阿比曲酮治疗转移性去势抵抗性前列腺癌: 随机II期RE-AKT试验的结果

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-07-01

OAAI

Rescigno, Pasquale; Porta, Nuria; Finneran, Laura; Riisnaes, Ruth; Figueiredo, Ines; Carreira, Suzanne; Flohr, Penny; Miranda, Susana; Bertan, Claudia; Ferreira, Ana; Crespo, Mateus; Rodrigues, Daniel Nava; Gurel, Bora; Nobes, Jenny; Crabb, Simon; Malik, Zafar; Ralph, Christy; McGovern, Ursula; Hoskin, Peter; Jones, Robert J.; Birtle, Alison; Gale, Joanna; Sankey, Peter; Jain, Suneil; McLaren, Duncan; Chadwick, Eliot; Espinasse, Aude; Hall, Emma; de Bono, Johann

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres

BMC CANCER

IF3.4

2024-06-07

OAAI

Hoskin, Peter; Lee, Marina; Dunkley, Denise; Danh, Mary; Wickens, Robin; Saunders, Geoff; Northey, Josh; Crabb, Simon; Mcfarlane, Vicky; Sadozye, Azmat; Cooper, Rachel; Mathew, Tony; Haslett, Kate; Reeves, Kim; Reed, Rachel; Bigos, Kamilla; Williams, Kaye J.; Rowling, Emily; Choudhury, Ananya; Dancer, Sonia; Smith, Deb; Griffiths, Gareth

Intraoperative electron radiotherapy in rectal cancer (ELECTRA): A feasibility trial

ANNALS OF ONCOLOGY

IF65.4

2024-06-01

PREAI

Ewings, S.; Griffiths, D.; Cozens, K.; Crabb, S.; Hawkins, M.; Lawrence, M.; Yano, H.; West, M.; Mirnezami, A.

Phase 1/2a Open-label Clinical Trial of BI-1607, an Fc Engineered Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors - CONTRAST

CANCER RESEARCH

IF16.6

2024-05-02

PREAI

Cortes, Javier; Priego, Araceli; Cabanas, Elena Garralda; Lamito, Katerin Rojas; Lord, Simon; Goetze, Thorsten; Kuemmel, Sherko; Crabb, Simon; Borggren, Marie; Karlsson, Ingrid; Martensson, Linda; Ropenga, Anna; Teige, Ingrid; Wallin, Johan; Frendeus, Bjorn; McAllister, Andres

Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial

JOURNAL OF PATHOLOGY CLINICAL RESEARCH

IF3.7

2024-02-01

OAAI

Griffin, Jon; Down, Jenny; Quayle, Lewis A.; Heath, Paul R.; Gibb, Ewan A.; Davicioni, Elai; Liu, Yang; Zhao, Xin; Swain, Jayne; Wang, Dennis; Hussain, Syed; Crabb, Simon; Catto, James W. F.

Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective 尿路上皮癌的全身抗癌治疗: 英国肿瘤学家的观点

BRITISH JOURNAL OF CANCER

IF6.8

2024-01-08

OAAI

Jones, Robert J.; Crabb, Simon J.; Linch, Mark; Birtle, Alison J.; McGrane, John; Enting, Deborah; Stevenson, Robert; Liu, Kin; Kularatne, Bihani; Hussain, Syed A.

Patient experience of surveillance following radical treatment for muscle-invasive bladder cancer

BJU INTERNATIONAL

IF4.4

2023-12-25

PREAI

Hack, Joanna; Douglas, James; Makaroff, Lydia; Costin, Melanie; Kelly, Phil; Knight, Allen; Chamberlain, Sarah; Crabb, Simon

Ephrin signalling mediates resistance to programmed death ligand 1 (PD-L1) inhibition in urothelial carcinoma (UC)

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

PREAI

Yang, Y-H.; Cubuk, C.; Castellano Gauna, D. E.; Banchereau, R.; Kockx, M.; Rodriguez-Vida, A.; Duran Martinez, I.; Crabb, S.; van der Heijden, M. S.; Font Pous, A.; Gravis, G.; Anido Herranz, U.; Protheroe, A.; Ravaud, A.; Jackson-Spence, F.; Toms, C.; Mousa, K.; Prendergast, A.; Szabados, B. E.; Powles, T. B.

phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in non-urothelial, muscle invasive bladder cancer (ABACUS-2)II期研究新辅助阿特珠单抗在非尿路上皮，肌肉浸润性膀胱癌中的安全性和有效性 (ABACUS-2)

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

PREAI

Szabados, B. E.; Nogueron Martinez, E.; Alvarez Marquez, F. J.; Castellano Gauna, D. E.; Rodriguez-Vida, A.; Garcias de Espana, M. C.; Hussain, S. A.; Alvarez Fernandez, C.; Linch, M.; Bonfill Abella, T.; Goupil, M. Gross; Kelly, J.; Jones, R. J.; Crabb, S.; Beltran, L.; Garonce-Hediger, R.; Rakebrandt, N. J.; Georgescu, R.; Ackerman, C.; Powles, T. B.

Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial 评估尿路鳞状细胞癌 (AURORA) 患者的atezolizumab: 单臂，开放标签，多中心，II期临床试验的研究方案

BMC CANCER

IF3.4

2023-09-19

OAAI

Crabb, Simon; Wickens, Robin; Jane-Bibby, Sarah; Dunkley, Denise; Lawrence, Megan; Knight, Allen; Jones, Robert; Birtle, Alison; Huddart, Robert; Linch, Mark; Martin, Jonathan; Coleman, Adam; Boukas, Konstantinos; Markham, Hannah; Griffiths, Gareth

Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland 苏格兰晚期尿路上皮癌的avelumab一线维持治疗的成本-效果分析

FUTURE ONCOLOGY

IF2.6

2023-08-02

OAAI

Critchlow, Simone; Bullement, Ash; Crabb, Simon; Jones, Robert; Christoforou, Katerina; Amin, Amerah; Xiao, Ying; Kapetanakis, Venediktos; Benedict, Agnes; Chang, Jane; Kearney, Mairead; Eccleston, Anthony

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (vol 25, pg 1706, 2019)

NATURE MEDICINE

IF50

2023-03-21

OAAI

Powles, Thomas; Kockx, Mark; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; van der Heijden, Michiel S.; Szabados, Bernadett; Pous, Albert Font; Gravis, Gwenaelle; Herranz, Urbano Anido; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Mendez, Maria Jose; Suarez, Cristina; Linch, Mark; Prendergast, Aaron; van Dam, Pieter-Jan; Stanoeva, Diana; Daelemans, Sofie; Mariathasan, Sanjeev; Tea, Joy S.; Mousa, Kelly; Banchereau, Romain; Castellano, Daniel

Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial 在2期ProCAID临床试验中，接受Capivasertib和多西他赛治疗的转移性去势抵抗性前列腺癌患者的总体生存更新

EUROPEAN UROLOGY

IF25.2

2022-11-01

OAAI

Crabb, Simon J.; Griffiths, Gareth; Dunkley, Denise; Downs, Nichola; Ellis, Mary; Radford, Mike; Light, Michelle; Northey, Josh; Whitehead, Amy; Wilding, Sam; Birtle, Alison J.; Khoo, Vincent; Jones, Robert J.

研究方向